Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

著者: Paul Rutgeerts, Geert D’Haens, Stephan R. Targan, Eric Vasiliauskas, Stephen B. Hanauer, Daniel H. Present, Lloyd Mayer, R. A. van Hogezand, Tanja Braakman, Kimberly L. DeWoody, T Schaible, Sander J. H. van Deventer - Gastroenterology 1999 被引用: 1,095